Directrices de Laboratorio para la detección y diagnóstico de la Infección con el Nuevo Coronavirus 2019 (2019-nCoV)

Organización Panamericana de la Salud.
Washington; OPS; 01/02/2020. 5 p.
Não convencional em Inglês, Espanhol | BVSDIP, FIOCRUZ | ID: dip-4309

Documentos relacionados

  1. Recent advances in the nucleic acid-based diagnostic tool for coronavirus.
  2. A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients.
  3. A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay.
  4. Performance Characteristics of a High-Throughput Automated Transcription-Mediated Amplification Test for SARS-CoV-2 Detection.
  5. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.
  6. Evaluation of SARS-CoV-2 viral RNA in fecal samples.
  7. SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification.
  8. Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP).
  9. Comparison of Extraction Methods and Thermocyclers for SARS-CoV-2 Molecular Detection Using Clinical Specimens.
  10. A Public Health Laboratory Response to the Pandemic.